ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,225.33
-0.27%
Dow Jones
39,159.41
0.12%
Gold vs US Dollar
2,301.49
-0.83%
Brent Oil
84.695
0.61%
Bitcoin
61,046.36
-1.24%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. NextCure Inc (NXTC) Share Price

NXTC NextCure Inc

1.645
-0.055 (-3.24%)
Last Updated: 18:41:33
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 NextCure Inc NASDAQ:NXTC NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.055 -3.24 1.645 1.63 1.67 1.68 1.62 1.68 15,546 17:41:33   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations  -62.72M -2.2422 -0.74 46.16M
 Type  Size  Price  Time  Units 
 9 5 1.67 17:49:20 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore NXTC News
20/06/202421:10GLOBENextCure to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
18/06/202421:10EDGAR2Form 8-K - Current report
30/05/202421:05GLOBENextCure Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024
02/05/202421:05GLOBENextCure Provides Business Update and Reports First Quarter 2024 Financial Results
24/04/202421:05GLOBENextCure to Present Phase 1b Data of NC410 in Combination with Pembrolizumab at ASCO 2024
08/04/202412:00GLOBENextCure and LCB Present Preclinical Data on B7-H4 Antibody Drug Conjugate at AACR 2024
04/04/202412:05GLOBENextCure Appoints Dr. Rakesh Dixit to Scientific Advisory Board
Period
Draw mode
Data Downloads for NXTC

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest NextCure Inc Articles